Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

By impounding iron, FHC foils cell suicide, fuels inflammation

12.11.2004


A research team based at the University of Chicago may have found a way to manipulate cell suicide, also known as programmed cell death, a normal process that regulates cell number but that goes awry in chronic inflammatory disorders, cancer and other diseases.



In the 12 Nov. 2004 issue of the journal Cell, the scientists show that a key step in the process of preventing cell suicide is the induction of ferritin heavy chain (FHC), a protein that collects and hoards iron. By sequestering iron -- which cells with suicidal tendencies need to make the harmful substances that induce death -- FHC prevents cellular suicide.

This finding suggests that drugs that modulate FHC or iron metabolism could provide a new and effective approach to anti-inflammatory therapy without the side effects, such as weakening the immune system, that come with current treatments. "In a long and complicated biochemical chain, this is one of the final links, which is exactly what we want," said study author Guido Franzoso, M.D., Ph.D., associate professor in the Ben May Institute for Cancer Research at the University of Chicago. "If we tamper with the front end, it changes everything, but boosting or blocking a downstream component allows us to select for a specific response."


Programmed cell death, also known as apoptosis, is the mechanism all multi-cellular organisms use to eliminate excess or damaged cells. Each year, through a balance of cell death and cell division, humans lose and regain a mass of cells roughly equal to their weight.

When a virus attacks an organism, for example, infected cells commit suicide to protect their healthy neighbors. At the same time, white blood cells multiply rapidly to battle the invader. Once the virus is eliminated, however, most of those virus-chasing white blood cells orchestrate their own demise. If they fail to thin their ranks sufficiently, they keep accumulating, infection after infection, which can lead to autoimmune diseases, such as arthritis, in which left-over warrior cells that no longer have an enemy turn on the self.

The researchers focused on NF-kB, a family of transcription factors -- proteins that turn on or off specific genes. The NF-kB family plays a crucial role in regulating immune and inflammatory responses to microbial invasion. During the early stages of an infection, for instance, NF-kB prevents white blood cells from dying off, allowing them to multiply quickly to fight off infection.

The problem of chronic inflammation begins when these lymphocytes evade cell death after winning the battle. In diseases like Crohn’s or arthritis they can turn their weaponry on healthy cells, which they misidentify as invaders, causing lasting disease and tissue damage. A similar process, when dysfunctional cells fail to die, plays a key role in the accumulation of cancerous cells and then protects those cells from radiation and chemotherapies designed to provoke tumor cell suicide.

Drugs that inhibit NF-kB are already in use for inflammatory bowel disease and certain cancers, such as Hodgkin’s lymphoma and multiple myeloma. But the tasks controlled by NF-kB are so wide ranging that blocking them globally can have serious side effects, such as reduced ability to fight off an infection.

"The goal has been to find new compounds that disrupt unwanted cell survival, but that act downstream from NF-kB so that they won’t harm the immune system," Franzoso said. For a long time that concept was a fantasy, he added, but "as we learn more about this pathway, it has become realistic." NF-kB acts through one subset of genes to influence immunity and a different subset to cause programmed cell death.

To map out those genes, Franzoso and colleagues used a "death-trap" screen. They exposed cells to TNF-Ą, a biochemical signal that can trigger cell death, then collected DNA from cells that survived. Several rounds of this process produced a library of potential protective genes. Next, they used microarrays to detect the genes that were boosted most though this selective process. "This system told us which genes were most enriched by selection," Franzoso said, which provided "a semiquantitative indication of protective efficacy." When they looked closer at each gene associated with survival after exposure to TNF-Ą, they found that FHC was the "pivotal mediator" preventing cell death.

Next, they tracked down the mechanism FHC uses to block apoptosis. They found that by hiding iron, FHC prevented the accumulation of oxygen radicals ¡V extremely unstable molecules that can damage other molecules and cell structures. Without an accumulation of oxygen radicals, cells are unable to take the final steps toward programmed cell death.

"The data indicate that the antioxidant activity of FHC involves iron sequestration and that this sequestration is crucial for suppression of death of white blood cells induced by proinflammatory factors," the authors note. These findings identify FHC as the mechanism "by which NF-kB controls the cascade of intracellular events that ultimately lead to cell suicide."

The next step is to develop drugs that can reduce or raise FHC levels. Lower levels could prevent inflammation and may also enhance the effects of anti-cancer therapies. Higher levels may prevent the unwanted cell death that occurs in neuro-degenerative disorders such as Parkinson’s and Alzheimer’s disease. "Not all that long ago, the NF-kB family, despite it crucial role in so many processes, was a complete puzzle," said Franzoso. "Now we have most of the pieces in place; we know how they fit together. The goal is to use this knowledge to make better therapies."

John Easton | EurekAlert!
Further information:
http://www.uchospitals.edu

More articles from Life Sciences:

nachricht Water forms 'spine of hydration' around DNA, group finds
26.05.2017 | Cornell University

nachricht How herpesviruses win the footrace against the immune system
26.05.2017 | Helmholtz-Zentrum für Infektionsforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

How herpesviruses win the footrace against the immune system

26.05.2017 | Life Sciences

Water forms 'spine of hydration' around DNA, group finds

26.05.2017 | Life Sciences

First Juno science results supported by University of Leicester's Jupiter 'forecast'

26.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>